Skip to content
AwardedPOLGoods

130/PN/2026 - Dostawa produktu leczniczego Lisocabtagene maraleucel dla UCK

Published
Published 26 May 2026
Deadline
Closed 1 July 2026

Overview

Uniwersyteckie Centrum Kliniczne procured the pharmaceutical product Lisocabtagene maraleucel in specified quantities and assortment for hospital use. The contract was awarded on 1 July 2026 to a consortium of Urtica Sp. z o.o. and Bristol Myers Squibb Polska Sp. z o.o. for 25,963,200 PLN, with successive deliveries to be made to the hospital pharmacy at the contractor's expense.

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Open
Published
26 May 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
PLN 25,963,200
Award date
1 July 2026
Contract period
— → 26 June 2027
Winner
  • Konsorcjum firm: Urtica Sp. z o.o. i i Bristol Myers Squibb Polska Sp. z o.o

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    10 July 2026

  2. Contract Notice

    25 June 2026

  3. Contract Notice

    16 June 2026

  4. Contract Notice

    26 May 2026

Contracting authority

  • Uniwersyteckie Centrum Kliniczne

    Procuring entity

    Gdańsk, POL

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 130/PN/2026 - Dostawa produktu leczniczego Lisocabtagene maraleucel dla UCK — won by Konsorcjum firm: Urtica Sp. z o.o. i i Bristol Myers Squibb Polska Sp. z o.o — Skim